| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/05/2011 | US20110104131 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 05/05/2011 | US20110104119 Chimeric Vectors |
| 05/05/2011 | US20110104083 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |
| 05/05/2011 | US20110104069 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | CA2779104A1 Ocular drug delivery devices |
| 05/05/2011 | CA2774704A1 Ophthalmic formulation and method of manufacture thereof |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315586A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | CN1870997B Treatment agent for keratoconjunctival disorder |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof |
| 05/04/2011 | CN102046173A Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
| 05/04/2011 | CN102046170A Methods of treating mammals with eustachian tube dysfunctions |
| 05/04/2011 | CN102046168A PAI-1 expression and activity inhibitors for the treatment of ocular disorders |
| 05/04/2011 | CN102046166A Methods of treating dry eye |
| 05/04/2011 | CN102040643A Ciclesonide nitrate derivative |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040600A Substituted 1-azabicyclo (2, 2, 2) octane quaternary ammonium salt and use thereof |
| 05/04/2011 | CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester |
| 05/04/2011 | CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl |
| 05/04/2011 | CN102038868A Traditional Chinese medicine formula for treating Meniere's syndrome |
| 05/04/2011 | CN102038792A External medicament for treating otitis media |
| 05/04/2011 | CN102038785A Quality control method for traditional Chinese medicinal preparation of children eyesight pills |
| 05/04/2011 | CN102038644A Lutein water-soluble powder and preparation process thereof |
| 05/04/2011 | CN102038638A Clindamycin hydrochloride injection and preparation method thereof |
| 05/04/2011 | CN101632779B Medicament for treating labyrinthine syndrome and preparation method thereof |
| 05/04/2011 | CN101284031B Hairy holly root extract, its preparation and application |
| 05/04/2011 | CN101125146B Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor |
| 05/04/2011 | CN101014580B Morpholine compound |
| 05/03/2011 | CA2622975C Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2421109C Efficient method for producing compositions enriched in anthocyanins |
| 05/03/2011 | CA2400778C Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
| 04/28/2011 | WO2011049958A2 Modulation of gel temperature of poloxamer-containing formulations |
| 04/28/2011 | WO2011049954A2 Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders |
| 04/28/2011 | WO2011049475A1 The new application of 2-pyrrolidone derivatives |
| 04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
| 04/28/2011 | WO2011049053A1 Intestinal mucosa-inherent myeloid cells inhibiting t cell activation and utilization of same |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011005864A3 Ophtalmic ethyleneoxide butyleneoxide block copolymer compositions |
| 04/28/2011 | WO2010125576A3 A process for isolation of lutein and zeaxanthin crystals from plant sources |
| 04/28/2011 | US20110098640 Visual indication of rupture of drug reservoir |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098460 SiRNA Useful to Suppress expression of eIF-5A1 |
| 04/28/2011 | US20110098360 Adamantane derivative for inhibiting toxicity of amyloid oligomer |
| 04/28/2011 | US20110098359 Compositions and Methods for Treatment of Glaucoma |
| 04/28/2011 | US20110098355 Method of preparing a latanoprost ophthalmic solution and resulting solution |
| 04/28/2011 | US20110098354 Method of preparing a latanoprost ophthalmic solution and the resulting solution |
| 04/28/2011 | US20110098337 Inhibitors of RTP801 and their use in disease treatment |
| 04/28/2011 | US20110098330 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 04/28/2011 | US20110098314 Statins for the treatment of ocular hypertension and glaucoma |
| 04/28/2011 | US20110098312 Methods for preventing the development of retinopathy by the oral administration of nnr ligands |
| 04/28/2011 | US20110098293 Inhibitors of Protein Tyrosine Kinase Activity |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097425 Methods of Treating Epiphora |
| 04/28/2011 | US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists |
| 04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
| 04/28/2011 | US20110097330 Novel Gene Disruptions, Compostitions and Methods Relating Thereto |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | CA2778401A1 Integrin alpha 8-beta 1-specific monoclonal antibody |
| 04/27/2011 | EP2314697A1 Streptococcus pneumoniae proteins and nucleic acids |
| 04/27/2011 | EP2314689A2 Antisense compounds targeted to connexins and methods of use thereof |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2314313A1 Vaccine against streptococcus pneumoniae |
| 04/27/2011 | EP2314299A1 Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin |
| 04/27/2011 | EP2313157A2 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 04/27/2011 | EP2313104A1 Thiolated chitosan gel |
| 04/27/2011 | EP2313103A1 Method of treating blepharitis |
| 04/27/2011 | EP2313092A1 Polyunsaturated fatty acids for improving vision |
| 04/27/2011 | EP1796624B1 Use of a viscoelastic composition for treating increased intraocular pressure |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1118660B1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102036675A Use of black soybean for treating ophthalmic diseases |
| 04/27/2011 | CN102028889A Chinese medicinal preparation for treating presbyopia, myopia, hypermetropia and glaucoma |
| 04/27/2011 | CN102028868A Medicine composition for treating senile cataract and preparation method thereof |
| 04/27/2011 | CN102028866A Traditional Chinese medicine prescription for treating nerve deafness |
| 04/27/2011 | CN102028817A Externally applied drug for preventing and treating myopia and amblyopia and using method of drug |
| 04/27/2011 | CN102028757A Processing method of mulberry composite extract |
| 04/27/2011 | CN102028697A Non-ionic surface active agent-containing Latanoprost eye drop and preparation method thereof |
| 04/27/2011 | CN102028694A Application of Fasudil in preparing medicaments for treating glaucoma through ophthalmic drug delivery |
| 04/27/2011 | CN101773653B Chinese medicine composition for treating ablepsia and preparation method thereof |
| 04/27/2011 | CN101575341B Amidocyanogen amido xanthone pyridine derivant, and preparation method and application thereof |
| 04/27/2011 | CN101547695B Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/27/2011 | CN101439091B Agent for nursing eye skin by eliminating and alleviating cell fatigue of eye skin |
| 04/27/2011 | CN101371899B Medicine for treating tympanitis |
| 04/27/2011 | CN101167866B Orally-administered traditional Chinese medicinal composition for treating purulent tympanitis |